Pipeline
We specialize in drug targets related to inflammatory and rare diseases. We continuously expand our portfolio of assets for both in-house development and partnerships.
Disease Area
Indication
Drug target
Molecule Generation
In vitro testing
Pre-clinical
IND-Ready
Inflammation
UNDISCLOSED
Undisclosed
UNDISCLOSED
Undisclosed
Metabolic & Genetic Disorders
Kidney Disease
Undisclosed